Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

Medically reviewed by Erika Prouty, PharmD Key Takeaways There are two types of complement 3 glomerulopathy: dense deposit ...

A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

CNIO researchers identified complement system genes linked to pancreatic cancer susceptibility and prognosis. Mutations in ...

Bringing Decades of Successful Biotech Company Growth, Financing, IPO and M&A ExpertiseNORFOLK, Va.--(BUSINESS WIRE)--ReAlta ...

This knowledge would help identify individuals who could benefit from early detection programmes, which are essential for a ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes related to the predisposition ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

European Commission approves Sobi’s Aspaveli for the treatment of C3G and primary IC-MPGN: Stockholm Monday, January 19, 2026, 10:00 Hrs [IST] Sobi, a global biopharma company u ...